vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Knife River Corp (KNF). Click either name above to swap in a different company.

Knife River Corp is the larger business by last-quarter revenue ($755.1M vs $487.7M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). Knife River Corp runs the higher net margin — 4.2% vs -10.1%, a 14.4% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 14.9%). Knife River Corp produced more free cash flow last quarter ($138.2M vs $-69.0M). Over the past eight quarters, Knife River Corp's revenue compounded faster (51.4% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Columbia River Knife & Tool, Inc. (CRKT) is an American knife company established in 1994, and currently based in Tualatin, Oregon, United States. The company's president and sales executive is Rod Bremer and the finance executive is Peggy Bremer.

CLOV vs KNF — Head-to-Head

Bigger by revenue
KNF
KNF
1.5× larger
KNF
$755.1M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+29.8% gap
CLOV
44.7%
14.9%
KNF
Higher net margin
KNF
KNF
14.4% more per $
KNF
4.2%
-10.1%
CLOV
More free cash flow
KNF
KNF
$207.2M more FCF
KNF
$138.2M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
KNF
KNF
Annualised
KNF
51.4%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
KNF
KNF
Revenue
$487.7M
$755.1M
Net Profit
$-49.3M
$32.0M
Gross Margin
19.2%
Operating Margin
-10.1%
8.6%
Net Margin
-10.1%
4.2%
Revenue YoY
44.7%
14.9%
Net Profit YoY
-123.2%
37.6%
EPS (diluted)
$0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
KNF
KNF
Q4 25
$487.7M
$755.1M
Q3 25
$496.6M
$1.2B
Q2 25
$477.6M
$833.8M
Q1 25
$462.3M
$353.5M
Q4 24
$337.0M
$657.2M
Q3 24
$331.0M
$1.1B
Q2 24
$356.3M
$806.9M
Q1 24
$346.9M
$329.6M
Net Profit
CLOV
CLOV
KNF
KNF
Q4 25
$-49.3M
$32.0M
Q3 25
$-24.4M
$143.2M
Q2 25
$-10.6M
$50.6M
Q1 25
$-1.3M
$-68.7M
Q4 24
$-22.1M
$23.3M
Q3 24
$-9.2M
$148.1M
Q2 24
$7.4M
$77.9M
Q1 24
$-19.2M
$-47.6M
Gross Margin
CLOV
CLOV
KNF
KNF
Q4 25
19.2%
Q3 25
23.6%
Q2 25
18.9%
Q1 25
-2.7%
Q4 24
17.4%
Q3 24
24.5%
24.7%
Q2 24
30.3%
21.8%
Q1 24
23.6%
2.0%
Operating Margin
CLOV
CLOV
KNF
KNF
Q4 25
-10.1%
8.6%
Q3 25
-4.9%
17.9%
Q2 25
-2.2%
10.6%
Q1 25
-0.3%
-23.4%
Q4 24
-6.4%
6.7%
Q3 24
-2.7%
18.9%
Q2 24
2.0%
14.5%
Q1 24
-6.5%
-16.3%
Net Margin
CLOV
CLOV
KNF
KNF
Q4 25
-10.1%
4.2%
Q3 25
-4.9%
11.9%
Q2 25
-2.2%
6.1%
Q1 25
-0.3%
-19.4%
Q4 24
-6.6%
3.5%
Q3 24
-2.8%
13.4%
Q2 24
2.1%
9.7%
Q1 24
-5.5%
-14.5%
EPS (diluted)
CLOV
CLOV
KNF
KNF
Q4 25
$0.56
Q3 25
$2.52
Q2 25
$0.89
Q1 25
$-1.21
Q4 24
$0.42
Q3 24
$2.60
Q2 24
$1.37
Q1 24
$-0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
KNF
KNF
Cash + ST InvestmentsLiquidity on hand
$78.3M
$73.8M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$308.7M
$1.6B
Total Assets
$541.0M
$3.7B
Debt / EquityLower = less leverage
0.71×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
KNF
KNF
Q4 25
$78.3M
$73.8M
Q3 25
$30.7M
Q2 25
$26.6M
Q1 25
$86.1M
Q4 24
$194.5M
$236.8M
Q3 24
$288.0M
$220.4M
Q2 24
$254.8M
$15.5M
Q1 24
$208.3M
$128.4M
Total Debt
CLOV
CLOV
KNF
KNF
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.4B
Q1 25
$1.2B
Q4 24
$677.4M
Q3 24
$678.5M
Q2 24
$679.5M
Q1 24
$680.6M
Stockholders' Equity
CLOV
CLOV
KNF
KNF
Q4 25
$308.7M
$1.6B
Q3 25
$340.9M
$1.6B
Q2 25
$344.2M
$1.5B
Q1 25
$336.1M
$1.4B
Q4 24
$341.1M
$1.5B
Q3 24
$342.2M
$1.4B
Q2 24
$324.9M
$1.3B
Q1 24
$292.5M
$1.2B
Total Assets
CLOV
CLOV
KNF
KNF
Q4 25
$541.0M
$3.7B
Q3 25
$559.7M
$3.7B
Q2 25
$575.0M
$3.6B
Q1 25
$583.7M
$3.3B
Q4 24
$580.7M
$2.9B
Q3 24
$653.0M
$2.9B
Q2 24
$674.2M
$2.7B
Q1 24
$671.8M
$2.5B
Debt / Equity
CLOV
CLOV
KNF
KNF
Q4 25
0.71×
Q3 25
0.74×
Q2 25
0.93×
Q1 25
0.83×
Q4 24
0.46×
Q3 24
0.47×
Q2 24
0.52×
Q1 24
0.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
KNF
KNF
Operating Cash FlowLast quarter
$-66.9M
$195.9M
Free Cash FlowOCF − Capex
$-69.0M
$138.2M
FCF MarginFCF / Revenue
-14.1%
18.3%
Capex IntensityCapex / Revenue
0.4%
7.6%
Cash ConversionOCF / Net Profit
6.12×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$-69.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
KNF
KNF
Q4 25
$-66.9M
$195.9M
Q3 25
$12.1M
$250.4M
Q2 25
$5.4M
$-42.6M
Q1 25
$-16.3M
$-125.3M
Q4 24
$34.8M
$172.4M
Q3 24
$50.0M
$239.7M
Q2 24
$44.8M
$-46.6M
Q1 24
$25.9M
$-43.2M
Free Cash Flow
CLOV
CLOV
KNF
KNF
Q4 25
$-69.0M
$138.2M
Q3 25
$11.4M
$188.7M
Q2 25
$4.8M
$-196.2M
Q1 25
$-16.5M
$-200.2M
Q4 24
$33.3M
$127.2M
Q3 24
$49.6M
$216.1M
Q2 24
$44.4M
$-106.5M
Q1 24
$25.5M
$-86.9M
FCF Margin
CLOV
CLOV
KNF
KNF
Q4 25
-14.1%
18.3%
Q3 25
2.3%
15.7%
Q2 25
1.0%
-23.5%
Q1 25
-3.6%
-56.6%
Q4 24
9.9%
19.3%
Q3 24
15.0%
19.6%
Q2 24
12.5%
-13.2%
Q1 24
7.3%
-26.4%
Capex Intensity
CLOV
CLOV
KNF
KNF
Q4 25
0.4%
7.6%
Q3 25
0.1%
5.1%
Q2 25
0.1%
18.4%
Q1 25
0.0%
21.2%
Q4 24
0.5%
6.9%
Q3 24
0.1%
2.1%
Q2 24
0.1%
7.4%
Q1 24
0.1%
13.3%
Cash Conversion
CLOV
CLOV
KNF
KNF
Q4 25
6.12×
Q3 25
1.75×
Q2 25
-0.84×
Q1 25
Q4 24
7.41×
Q3 24
1.62×
Q2 24
6.04×
-0.60×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

KNF
KNF

Services$347.2M46%
Ready Mix Concrete$88.4M12%
Contracting Services Public Sector$80.2M11%
Aggregates$73.9M10%
Energy Services Segment$56.2M7%
Liquid Asphalt$49.1M7%
Other$43.2M6%
Asphalt$22.7M3%

Related Comparisons